Form 4: Beta Bionics Executive Sells Shares
Insider Transaction (Form 4)
Steven Jon Russell, Chief Medical Officer of Beta Bionics, Inc, sold 4,221 shares of common stock on September 2, 2026 for $19.11 per share.
Summary
- Open-market sale: disposed of 4,221 Common Stock at $19.11 ($80,676) on September 2, 2026; holds 169,628 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $80,676 of stock on the open market.
Insider Transactions
Steven Jon Russell — Officer (Chief Medical Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-02 | Open-market sale | Common Stock | 4,221 | $19 | $80.7K | 169,628 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-02 | Open-market sale (4,221 shares) |
Keywords
insider transaction, Form 4, BBNX, Beta Bionics, Inc., bearish, Steven Jon Russell
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.